Back to results
CompletedPhase 1

A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901

NCT01526473

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Duke University Medical Center

Durham, North Carolina, United States

View on ClinicalTrials.gov
A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901 — TrialFind